Free Trial

Origin Enterprises (OGN) Competitors

Origin Enterprises logo
GBX 3.50 +0.13 (+3.70%)
As of 04/30/2025 08:22 AM Eastern

OGN vs. INDV, SLS, ERGO, SLN, BMY, AMYT, GPH, IGC, ARTL, and PHAR

Should you be buying Origin Enterprises stock or one of its competitors? The main competitors of Origin Enterprises include Indivior (INDV), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Bloomsbury Publishing (BMY), Amryt Pharma (AMYT), Global Ports (GPH), India Capital Growth (IGC), Alpha Real Trust (ARTL), and Pharos Energy (PHAR). These companies are all part of the "pharmaceutical products" industry.

Origin Enterprises vs.

Indivior (LON:INDV) and Origin Enterprises (LON:OGN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Indivior received 447 more outperform votes than Origin Enterprises when rated by MarketBeat users. However, 80.58% of users gave Origin Enterprises an outperform vote while only 80.43% of users gave Indivior an outperform vote.

CompanyUnderperformOutperform
IndiviorOutperform Votes
559
80.43%
Underperform Votes
136
19.57%
Origin EnterprisesOutperform Votes
112
80.58%
Underperform Votes
27
19.42%

Indivior presently has a consensus price target of GBX 1,650, indicating a potential upside of 89.98%. Given Indivior's higher possible upside, research analysts clearly believe Indivior is more favorable than Origin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Indivior
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Origin Enterprises
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Origin Enterprises has higher revenue and earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Origin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Indivior£1.40B0.97-£2.36M-£1.21-720.11
Origin Enterprises£183.08B0.00£3.62B£0.3510.12

In the previous week, Indivior had 2 more articles in the media than Origin Enterprises. MarketBeat recorded 3 mentions for Indivior and 1 mentions for Origin Enterprises. Origin Enterprises' average media sentiment score of 1.05 beat Indivior's score of 0.35 indicating that Origin Enterprises is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Indivior
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Origin Enterprises
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.7%. Origin Enterprises pays an annual dividend of GBX 17 per share and has a dividend yield of 485.7%. Indivior pays out -1,243.7% of its earnings in the form of a dividend. Origin Enterprises pays out 4,915.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Indivior has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500. Comparatively, Origin Enterprises has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500.

86.0% of Indivior shares are owned by institutional investors. Comparatively, 62.1% of Origin Enterprises shares are owned by institutional investors. 3.4% of Indivior shares are owned by company insiders. Comparatively, 0.4% of Origin Enterprises shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Origin Enterprises has a net margin of 1.98% compared to Indivior's net margin of -0.17%. Origin Enterprises' return on equity of 10.29% beat Indivior's return on equity.

Company Net Margins Return on Equity Return on Assets
Indivior-0.17% -0.77% 2.37%
Origin Enterprises 1.98%10.29%2.96%

Summary

Origin Enterprises beats Indivior on 11 of the 19 factors compared between the two stocks.

Get Origin Enterprises News Delivered to You Automatically

Sign up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OGN vs. The Competition

MetricOrigin EnterprisesFarm Products IndustryDefensive SectorLON Exchange
Market Cap£369.56M£125.95M£6.88B£2.56B
Dividend Yield6.03%3.00%3.16%4.97%
P/E Ratio10.126.3011.65132.78
Price / Sales0.0030.0785.81244,461.27
Price / Cash0.029.00146.2628.13
Price / Book0.011.142.884.55
Net Income£3.62B£375.04M£1.01B£5.84B
7 Day Performance8.70%-0.44%0.10%2.92%
1 Month Performance9.03%-0.08%1.42%8.98%
1 Year Performance6.06%-8.26%46.03%114.84%

Origin Enterprises Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OGN
Origin Enterprises
N/AGBX 3.50
+3.7%
N/A+6.1%£369.56M£183.08B10.1210,000Dividend Increase
Positive News
Gap Up
INDV
Indivior
2.3 of 5 stars
GBX 695
+5.3%
GBX 1,650
+137.4%
-41.0%£1.09B£1.40B-576.261,000
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
BMY
Bloomsbury Publishing
2.5 of 5 stars
GBX 571
+2.5%
GBX 825
+44.5%
+10.9%£460.76M£382.40M12.2234,300Gap Down
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
GPH
Global Ports
N/AN/AN/AN/A£231.21M£193.58M30,000.0020
IGC
India Capital Growth
N/AGBX 170
+2.1%
N/A-4.2%£146.78M£46.21M3.4361Gap Down
ARTL
Alpha Real Trust
N/AN/AN/AN/A£113.12M£8.46M96.445Gap Up
High Trading Volume
PHAR
Pharos Energy
N/AGBX 19.60
+1.8%
N/A-20.2%£97.77M£196.07M-2.08280News Coverage
Positive News

Related Companies and Tools


This page (LON:OGN) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners